Literature DB >> 19501792

The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study.

Hind T Hatoum1, Kasem S Akhras, Swu-Jane Lin.   

Abstract

We estimated the incremental clinical and economic burden of skin and skin structure infections (SSSI) in hospitalized patients using a matched cohort study design. Cases with SSSI as secondary diagnosis were matched with up to 4 randomly selected non-SSSI controls by age, gender, admission date, and ICD-9 code of principal diagnosis. Among the 1 472 965 hospitalizations episodes, 23 026 had SSSI as their secondary diagnosis. Matching was successful in 22 551 (98%) cases. Compared with controls (n = 87 811), the cases had an average mean unadjusted length of hospital stay (LOS) of 5 days longer and excess hospital charges over $21 000 and higher mortality rate (5.4% versus 3.5%). Adjusted estimates from regression models revealed that SSSI incurred on average 3.81 additional days and $14 794 excess hospitalization charges. Risk of mortality was significantly higher in the cases (odds ratio, 1.32). P value was <0.0001 for all unadjusted and adjusted outcomes. Compared with their matched controls, patients with SSSI had significantly longer LOS, higher mortality, and higher hospital charges.

Entities:  

Mesh:

Year:  2009        PMID: 19501792     DOI: 10.1016/j.diagmicrobio.2009.02.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  14 in total

1.  Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study.

Authors:  Douglas Challener; Jasmine Marcelin; Sue Visscher; Larry Baddour
Journal:  Hosp Pract (1995)       Date:  2017-09-27

2.  Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Authors:  Marcus J Zervos; Katherine Freeman; Lien Vo; Nadia Haque; Hiren Pokharna; Monika Raut; Myoung Kim
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  Sivextro (Tedizolid Phosphate) Approved for the Treatment of Adults with Acute Bacterial Skin and Skin-Structure Infections.

Authors:  Loretta Fala
Journal:  Am Health Drug Benefits       Date:  2015-03

4.  Ceftaroline in complicated skin and skin-structure infections.

Authors:  Paul O Hernandez; Sergio Lema; Stephen K Tyring; Natalia Mendoza
Journal:  Infect Drug Resist       Date:  2012-01-19       Impact factor: 4.003

5.  Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.

Authors:  Ashraf El Houfi; Nadeem Javed; Caitlyn T Solem; Cynthia Macahilig; Jennifer M Stephens; Nirvana Raghubir; Richard Chambers; Jim Z Li; Seema Haider
Journal:  Infect Drug Resist       Date:  2015-06-18       Impact factor: 4.003

6.  Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe.

Authors:  Dilip Nathwani; Christian Eckmann; Wendy Lawson; Caitlyn T Solem; Shelby Corman; Jennifer M Stephens; Cynthia Macahilig; Damien Simoneau; Richard Chambers; Jim Z Li; Seema Haider
Journal:  BMC Infect Dis       Date:  2014-09-02       Impact factor: 3.090

7.  Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients.

Authors:  Thomas L Walsh; Lynn Chan; Chelsea I Konopka; Michael J Burkitt; Matthew A Moffa; Derek N Bremmer; Monika A Murillo; Courtney Watson; Noreen H Chan-Tompkins
Journal:  BMC Infect Dis       Date:  2016-11-29       Impact factor: 3.090

Review 8.  Delafloxacin: design, development and potential place in therapy.

Authors:  Francisco Javier Candel; Marina Peñuelas
Journal:  Drug Des Devel Ther       Date:  2017-03-20       Impact factor: 4.162

9.  Evaluation of Physician Prescribing Patterns For Antibiotics in the Treatment of Nonnecrotizing Skin and Soft Tissue Infections.

Authors:  Michael C Ezebuenyi; Fatima Brakta; Ifeanyichukwu O Onor; Daniel F Sarpong; Kendrea Bryant-Burks; Julio E Figueroa
Journal:  P T       Date:  2018-05

10.  Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital.

Authors:  Li Wen Loo; Yi Xin Liew; Winnie Lee; Piotr Chlebicki; Andrea Lay-Hoon Kwa
Journal:  Infect Dis Ther       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.